About Avation
Avation is a company based in Columbus (United States) founded in 1999 by Manish Vaishya. It operates as a Direct-to-Consumer (D2C) and HealthTech. Avation has raised $34.92 million across 2 funding rounds from investors including Medtronic, Asahi Kasei and ShangBay Capital. Avation offers products and services including Vivally® System. Avation operates in a competitive market with competitors including Tulavi Nerve Therapeutics, BioCircuit, RxFunction, Epineuron and Monarch Bioimplants, among others.
- Headquarter Columbus, United States
- Founders Manish Vaishya
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website avation.com
- Social LinkedIn Facebook
- Legal Name Avation Medical
- Total Equity Funding$34.92M (USD)
in 2 rounds
- Latest Funding Round$22M (USD), Series C
Feb 2024
- InvestorsMedtronic
& 6 more
Products & Services of Avation
Avation offers a comprehensive portfolio of products and services, including Vivally® System.
Wearable treatment for overactive bladder is provided.
Funding Insights of Avation
Avation has successfully raised a total of $34.92M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $22 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.92M
- Total Rounds 2
- Last Round Series C — $22M
- First Round $12.92M
(Feb 2021)
- Investors Count 7
All 2 funding rounds of Avation with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $22M | Series C | – | ShangBay Capital, Asahi Kasei | |
| Feb 2021 | $12.92M | Series B | – | – | – |
7 investors in total: 7 institutional.
Investors in Avation
Avation has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Asahi Kasei and ShangBay Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | shangbaycapital.com | - | |
Angelini Ventures is focused on investing in BioTech and Digital Health. | – | angeliniventures.com | Rome, Italy | |
Healthcare venture capital investments are made by Arboretum Ventures. | – | arboretumvc.com | Ann Arbor, United States | |
Avestria Ventures is focused on funding women's health and life science ventures. | – | avestria.vc | San Francisco, United States | |
CDMO focused on manufacturing of liquid, solid & injectable drug formulations | 1931 | asahi-kasei.com | Tokyo, Japan | |
JobsOhio is focused on economic development in Ohio. | – | jobsohio.com | Columbus, United States | |
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States |
Investor details for Avation
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Avation
17 people are tracked at Avation (5 in leadership, 7 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Manish Vaishya | Co-Founder & CTO | Leadership |
Jill Schiaparelli | CEO & Director | Leadership |
Darren Wennen | CMO | Leadership |
Jackie Gerberry | Senior Director Finance & Human Resources | Leadership |
Constantin Buliga | Director Software Development | Leadership |
Tom Shehab | Chairperson | Board & advisors |
Ali Rezai | Board Observer | Board & advisors |
Raymond Huggenberger | Director | Board & advisors |
Renee Selman | Director | Board & advisors |
Kevin Wasserstein | Director | Board & advisors |
Robert Fong | Board Observer | Board & advisors |
John Whalen | Board Observer | Board & advisors |
Tracy Cameron | Clinical Consultant | Team |
Roy Hansen | Quality Manager | Team |
David DeMuth | Sr. Operations Manager | Team |
Anna Susel | Clinical Operations Associate | Team |
Cheryl Shaw | Senior Executive Assistant/Office Manager | Team |
Complete people profiles for Avation
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Avation
3 dated milestones of Avation across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Avation is founded.
- Funding First funding round of $12.9M.
- Funding Latest funding round, Series C, of $22.0M.
Competitors of Avation
Avation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tulavi Nerve Therapeutics, BioCircuit, RxFunction, Epineuron and Monarch Bioimplants, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tulavi.com | 2020 | Mountain View, United States | $4M | – | Therapeutic devices for neurally mediated diseases are developed. | |
| biocircuit.com | 2016 | Atlanta, United States | $13.65M | – | Non-invasive electrophysiology devices are developed to monitor peripheral nerves. | |
| rxfunction.com | 2010 | Minneapolis, United States | $39.95M | 30 | Wearable prostheses for sensory peripheral neuropathy patients are developed. | |
| epineurontech.com | 2016 | Hamilton, Canada | – | – | Medical devices for peripheral nerve injury treatment are provided. | |
| monarchbioimplants.com | 2016 | Root, Switzerland | $24.93M | – | Developer of bioimplant for peripheral nerve repair | |
| micro-leads.com | 2014 | Boston, United States | – | – | Micro-cuff electrodes and wireless pulse generators for neuromodulation are developed. | |
| renerva.com | 2017 | Pittsburgh, United States | $1.28M | – | Implants for peripheral nerve repair are developed for injury treatment. | |
| photothera.com | 1997 | Carlsbad, United States | $80.5M | – | Provides advanced laser therapy solutions for healthcare applications. |
Detailed competitors of Avation
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Avation
The website of Avation (avation.com) receives about 4K visits a month.
- Monthly visits4K
▼ 18.7% vs previous month
Latest news on Avation
Complete news archive for Avation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Avation
10 companies that operate in the same segment as Avation (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Avation
Avation was founded in 1999 and raised its 1st funding round 22 years after it was founded.
Avation is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.
Avation is a funded company, having raised a total of $34.92M across 2 funding rounds to date. The company's 1st funding round was a Series B of $12.92M, raised on Feb 2021.
Avation is focused on providing innovative solutions for overactive bladder (OAB) through the Vivally System, a wearable at-home treatment. The system is FDA-cleared and targets symptoms like incontinence and urgency with physiologic closed-loop controlled transcutaneous tibial nerve stimulation. It is supported by a mobile app for tracking progress and customer care for patient assistance. The healthcare sector is primarily served, with solutions designed for both patients and providers to improve quality of life.
Avation's top competitors include Tulavi Nerve Therapeutics, Epineuron and RxFunction.
Avation offers Vivally® System.
Avation has 7 investors. Key investors include Medtronic, Asahi Kasei, ShangBay Capital, Angelini Ventures, and JobsOhio.
Avation operates through Avation Medical.